Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
842
-
Total shares
-
39.3M
-
Shares change
-
-4.4M
-
Total reported value, excl. options
-
$5.07B
-
Value change
-
-$572M
-
Put/Call ratio
-
1.17
-
Number of buys
-
246
-
Number of sells
-
-420
-
Price
-
$129.16
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2023
866 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q1 2023.
ISHARES TR - ISHARES BIOTECH (IBB) has 842 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.3M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (11.2M shares), MORGAN STANLEY (2.92M shares), CITIGROUP INC (2M shares), GOLDMAN SACHS GROUP INC (1.83M shares), Royal Bank of Canada (1.82M shares), UBS Group AG (1.36M shares), BNP PARIBAS ARBITRAGE, SNC (1.34M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (989K shares), WELLS FARGO & COMPANY/MN (741K shares), and COMMERCE BANK (735K shares).
This table shows the top 842 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.